Business Context and Reporting Period
This Form 8-K Current Report was filed by Ginkgo Bioworks Holdings, Inc. on September 4, 2024, covering events occurring on September 3, 2024. The filing addresses regulatory status updates regarding the Company's securities listed on the New York Stock Exchange (NYSE).
Key Financial Metrics
This filing is a current report regarding listing status and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes
- Warrant Delisting: The NYSE initiated proceedings to delist the Company's public warrants (trading symbol "DNA.WS") due to "abnormally low" trading price levels. Trading in these warrants was immediately suspended.
- Common Stock Compliance: The Company regained compliance with the NYSE's minimum price criteria for its Class A Common Stock (trading symbol "DNA"). The stock was removed from the noncompliant issuers list.
- Price Thresholds: As of August 30, 2024, the closing price and the 30-day average closing price of the Class A Common Stock were both above the $1.00 threshold required for continued listing.
Outlook, Risks, and Management Commentary
Management confirmed that trading in the Class A Common Stock remains unaffected and will continue on the NYSE. The filing highlights the risk of delisting associated with low trading prices, which materialized for the warrants but was successfully mitigated for the common stock through price recovery. No forward-looking guidance or financial outlook is provided in this specific report.
Investor Verification Checklist
- Verify the current trading status and liquidity of the suspended warrants (DNA.WS).
- Confirm the continued listing status of the Class A Common Stock (DNA) on the NYSE.
- Review the Company's most recent 10-Q or 10-K for financial performance metrics, as this 8-K contains no financial data.
- Monitor future price movements of the Class A Common Stock to ensure sustained compliance with the $1.00 minimum bid price requirement.